Bionano Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022

Go back to Bionano Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022
(NASDAQ: BNGO) Delayed: 1.13 --0 (-0%)
Previous Close $1.13    52 Week High
Open $1.13    52 Week Low
Day High $1.16    P/E N/A 
Day Low $1.13    EPS
Volume 79,950